Applications
Applications
Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Alzheimers Disease Research Foundation accepts applications.
From its returns
What it gave
Alzheimers Disease Research Foundation paid $37,323,497 in grants in the year ending December 2025.
| Year ending | Grants paid | Grants listed |
|---|---|---|
| December 2025 | $37,323,497 | 161 |
| December 2024 | $28,828,950 | 106 |
From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.
Focus and places
What it funds, and where
From the 267 grants listed on its returns for the years ending December 2024 to December 2025. A grant counts toward a focus only when it is linked to the charity that received it: 82 of 267 are.
Focus, by share of linked grant dollars
Where it gave, by number of grants
From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.
Grants
Recent grants to organizations
The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.
| Recipient | Year ending | Amount | Purpose |
|---|---|---|---|
| Mass General Brigham IncorporatedSomerville, Massachusetts | December 2025 | $1,955,000 | THE CUREALZ ALZHEIMER'S GENOME PROJECT |
| Mass General Brigham IncorporatedSomerville, Massachusetts | December 2025 | $575,000 | APOE4 ACCELERATES CD8 EXHAUSTION VIA GLUCOCORTICOID SIGNALING IN ALZHEIMER'S FEMALE CARRIERS |
| Mass General Brigham IncorporatedSomerville, Massachusetts | December 2025 | $431,250 | A NEW MODEL OF MICROGLIA GENETIC PERTURBATION IN VIVO TO SCREEN ALL RISK FACTORS ASSOCIATED WITH ALZHEIMER'S DISEASE |
| UNIVERSITY OF MICHIGANAnn Arbor, Michigan | December 2025 | $402,500 | NON-INVASIVE MODULATION OF MICROGLIA GENE EXPRESSION USING PERIPHERALLY ADMINISTERED ANTIBODY CONJUGATES |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITYNew York, New York | December 2025 | $402,500 | SEX-BIASED TLR7 SIGNALING IN DEMYELINATION AND ITS INHIBITION BY SMALL MOLECULES |
| UNIVERSITY OF CALIFORNIA IRVINEIrvine, California | December 2025 | $402,492 | PROTEOMIC SIGNATURES OF CEREBROVASCULAR NEUROPATHOLOGY IN DOWN SYNDROME WITH ALZHEIMER DISEASE |
| UNIVERSITY OF MICHIGANAnn Arbor, Michigan | December 2025 | $398,521 | UTILIZING HETEROGENEOUS MOUSE MODELS TO DISCOVER MECHANISMS UNDERLYING CALORIC RESTRICTION (CR) ON COGNITIVE OUTCOMES |
| WASHINGTON UNIVERSITY IN ST LOUISSt Louis, Missouri | December 2025 | $345,000 | APOE CONSORTIUM: INVESTIGATING POTENTIAL CELL AUTONOMOUS NEUROPROTECTION OF APOE PROTECTIVE VARIANTS |
| WASHINGTON UNIVERSITY IN ST LOUISSt Louis, Missouri | December 2025 | $345,000 | BAC: IDENTIFYING AGE-RELATED PROTEOMIC CHANGES THAT PREDICT FUTURE ONSET OF AMYLOID-BETA AGGREGATION IN ALZHEIMER'S DISEASE |
| WASHINGTON UNIVERSITY IN ST LOUISSt Louis, Missouri | December 2025 | $345,000 | BEE: MENINGEAL MAST CELL CONTROL OF CSF DYNAMICS IN HOMEOSTASIS AND ALZHEIMER'S DISEASE |
| BOSTON CHILDREN'S HOSPITALBoston, Massachusetts | December 2025 | $344,528 | NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE |
| Mass General Brigham IncorporatedSomerville, Massachusetts | December 2025 | $327,501 | EXPANDING POSTMORTEM BRAIN RESOURCES FOR ALZHEIMER'S DISEASE IN DIVERSE POPULATIONS |
| DUKE UNIVERSITY SCHOOL OF MEDICINEDurham, North Carolina | December 2025 | $320,033 | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES |
| Mass General Brigham IncorporatedSomerville, Massachusetts | December 2025 | $300,000 | UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY |
| NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS & STROKEBethesda, Maryland | December 2025 | $287,673 | BEE: HIGH-RESOLUTION MRI OF THE BRAIN BORDERS |
| Mass General Brigham IncorporatedSomerville, Massachusetts | December 2025 | $287,500 | BEE: HUMAN 3D NEURO-VASCULAR INTERACTION AND MENINGEAL LYMPHATICS MODELS WITH APPLICATION TO ALZHEIMER'S DISEASE |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINENew York, New York | December 2025 | $287,500 | NIC: ASTROCYTE INFLAMMATORY CONTRIBUTIONS TO AD |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLa Jolla, California | December 2025 | $287,500 | BEE: HOW DOES VASCULAR FATTY ACID METABOLISM REGULATE THE PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE? |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLa Jolla, California | December 2025 | $287,500 | NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION |
| STANFORD UNIVERSITYRedwood City, California | December 2025 | $287,500 | BAC: CHOROID PLEXUS AGING AND ALZHEIMER'S DISEASE |
| UNIVERSITY OF ROCHESTERRochester, New York | December 2025 | $287,500 | BEE: DOES SLYM FAILURE COMPROMISE GLYMPHATIC CLEARANCE IN ALZHEIMER'S DISEASE? |
| WASHINGTON UNIVERSITY IN ST LOUISSt Louis, Missouri | December 2025 | $287,500 | BAC: BRAIN REGION AND CELL-TYPE SPECIFIC AGING FROM ACCELERATED TO RESILIENT TRAJECTORIES |
| WASHINGTON UNIVERSITY IN ST LOUISSt Louis, Missouri | December 2025 | $287,499 | BAC: ESTABLISHING ISOGENIC MODELS OF HUMAN NEURON AGING AND PATHWAYS RELEVANT FOR ALZHEIMER'S DISEASE |
| UNIVERSITY OF CALIFORNIA IRVINEIrvine, California | December 2025 | $287,490 | NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGYCambridge, Massachusetts | December 2025 | $287,477 | BAC: INVESTIGATING LIPIDOMIC PERTURBATIONS IN THE CSF WITH AGE AND ALZHEIMER'S DISEASE PROGRESSION: TOWARD MECHANISTIC INSIGHTS AND ACCESSIBLE LIPID BIOMARKERS |
Showing 25 of the 267 grants listed on its returns for the years ending December 2024 to December 2025. From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.